Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | RGS12 | O14924 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | DGAT1 | O75907 | 4/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.42 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11340160 | 0.99 | CYP2C9 (0.81) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL11340158 | 0.99 | CYP2C9 (0.81) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10832489 | 0.97 | CYP2C9 (0.79) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10832486 | 0.97 | CYP2C9 (0.79) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10832483 | 0.97 | CYP2C9 (0.79) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL9973108 | 0.95 | CYP2C9 (0.75) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL11524858 | 0.95 | CYP2C9 (0.75) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL29799677 | 0.90 | CYP2C9 (0.67) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL8290975 | 0.88 | CYP2C9 (1.00) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL28215189 | 0.88 | CYP2C9 (0.73) | CYP2C9MAPTALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10982148-B2 | Liquid crystal device, method for producing same, and compound | JSR CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20200231875-A1 | LIQUID CRYSTAL DEVICE, METHOD FOR PRODUCING SAME, AND COMPOUND | JSR CORPORATION (JP) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10982148-B2 | Liquid crystal device, method for producing same, and compound | NLK, DDC, SET | CYP2C9 631/4885MAPT 472/4885ALDH1A1 3818/4885 |
| US-20200231875-A1 | LIQUID CRYSTAL DEVICE, METHOD FOR PRODUCING SAME, AND COMPOUND | NLK, DDC, SET | CYP2C9 631/4885MAPT 472/4885ALDH1A1 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.